WallStreetZenWallStreetZen

NASDAQ: GDTC
Cytomed Therapeutics Revenue

OverviewEarningsRevenue
DividendOwnership
Cytomed Therapeutics revenue was $253.43k for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GDTC annual revenue was $253.4k, with 395.9% growth year-over-year.

GDTC past revenue growth

How has GDTC's revenue growth performed historically?

Company
395.91%
Industry
514.01%
Market
41.01%
GDTC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GDTC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GDTC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GDTC revenue history

Current Revenue
$253.4k
Current Earnings
-$3.1M
Current Profit Margin
-1,227.1%

Be the first to know when GDTC announces revenue.

GDTC Revenue History By Year

GDTC Yearly RevenueGDTC RevenueGDTC ChangeGDTC Revenue Growth
2025-12-31$253.43k$202.32k+395.91%
2024-12-31$51.10kN/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A

1 of 1

Cytomed Therapeutics Revenue FAQ

What was GDTC's revenue last quarter?

Cytomed Therapeutics (NASDAQ: GDTC) reported Q4 2025 revenue of N/A up N/A year over year. In the same quarter last year, Cytomed Therapeutics's revenue was N/A.

What was Cytomed Therapeutics's revenue in 2025?

Cytomed Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $253.43 thousand, a 395.91% increase year over year.

How much does Cytomed Therapeutics make in a day?

Based on Cytomed Therapeutics annual revenue for the past five years, GDTC makes an average of $166.87 per day.

What was Cytomed Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Cytomed Therapeutics's revenue has grown 395.91% year over year. This is 118.1 percentage points lower than the US Biotechnology industry revenue growth rate of 514.01%. Cytomed Therapeutics's revenue in the past year totaled $253.43 thousand.

How much does Cytomed Therapeutics make in a year?

Cytomed Therapeutics's revenue by year for the past five years is:
  • Cytomed Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $253.43 thousand, a 395.91% increase year over year.
  • Cytomed Therapeutics's annual revenue for Dec 31, 2024 was $51.10 thousand, a Infinity% increase from 2023.
  • Cytomed Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Cytomed Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Cytomed Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.